Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion type Assertion NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_head.
- NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion description "[The molecular understanding of this sequence has had a profound impact on our understanding of the process(s) of colonic carcinogenesis and this understanding has begun to change the clinical care of patients with colonic polyps and cancer including changes in therapy of established CRCs (anti-epidermal growth factor receptor antibody therapy is no longer offered to patients with mutant KRAS CRCs), identification of high-risk groups (diagnosis of Lynch syndrome by molecular analysis of CRCs) and the management of precursor lesions (identification of the serrated polyp pathway to CRC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_provenance.
- NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion evidence source_evidence_literature NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_provenance.
- NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion SIO_000772 21266962 NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_provenance.
- NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion wasDerivedFrom befree-20150227 NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_provenance.
- NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_assertion wasGeneratedBy ECO_0000203 NP528265.RAHqoaq0yVdaYobvrGDSat4ILIyeu81PBOlD6HTNMQXVw130_provenance.